Exane Asset Management - Q4 2019 holdings

$81.4 Billion is the total value of Exane Asset Management's 28 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 93.3% .

 Value Shares↓ Weighting
LIN BuyLINDE PLC SHSstock$13,966,149,000
+6812.3%
65,190
+6162.2%
17.15%
+10967.1%
AGN BuyALLERGAN PLC SHSstock$11,164,710,000
+37.1%
58,402
+20.7%
13.71%
+119.3%
ZAYO BuyZAYO GROUP HLDGS INC COMstock$10,194,758,000
+31.2%
294,221
+28.4%
12.52%
+110.0%
T BuyATT INC COMstock$6,158,734,000
+32.3%
157,593
+28.1%
7.56%
+111.7%
TIF NewTIFFANY CO NEW COMstock$5,346,000,00040,000
+100.0%
6.57%
WAIR BuyWESCO AIRCRAFT HLDGS INC COMstock$3,993,990,000
+113.8%
362,431
+113.6%
4.91%
+242.1%
CY BuyCYPRESS SEMICONDUCTOR CORP COMstock$3,616,150,000
+23.9%
155,000
+24.0%
4.44%
+98.4%
CZR NewCAESARS ENTMT CORP COMstock$3,103,520,000228,200
+100.0%
3.81%
ATVI NewACTIVISION BLIZZARD INC COMstock$2,305,377,00038,798
+100.0%
2.83%
INXN NewINTERXION HOLDING N.V SHSstock$2,095,250,00025,000
+100.0%
2.57%
BMY SellBRISTOL MYERS SQUIBB CO COMstock$2,027,698,000
-80.3%
31,589
-84.4%
2.49%
-68.4%
OMN SellOMNOVA SOLUTIONS INC COMstock$1,958,924,000
-43.4%
193,761
-43.6%
2.41%
-9.4%
SPOT NewSPOTIFY TECHNOLOGY S A SHSstock$1,952,973,00013,059
+100.0%
2.40%
WMGI NewWRIGHT MED GROUP N V ORD SHSstock$1,828,190,00059,980
+100.0%
2.25%
FIT NewFITBIT INC CL Astock$1,439,487,000219,100
+100.0%
1.77%
MDCO NewMEDICINES CO COMstock$1,274,100,00015,000
+100.0%
1.56%
ASH SellASHLAND GLOBAL HLDGS INC COMstock$1,147,950,000
-88.1%
15,000
-88.1%
1.41%
-81.0%
TAK SellTAKEDA PHARMACEUTICAL CO LTD SPONSORED ADSstock$1,047,505,000
-2.8%
53,092
-15.2%
1.29%
+55.6%
PACB  PACIFIC BIOSCIENCES CALIF IN COMstock$1,021,539,000
-0.4%
198,7430.0%1.26%
+59.5%
FTSV SellFORTY SEVEN INC COMstock$932,045,000
+55.8%
23,674
-74.6%
1.14%
+149.5%
KL NewKIRKLAND LAKE GOLD LTD COMstock$882,108,00020,000
+100.0%
1.08%
AMGN SellAMGEN INC COMstock$850,013,000
-81.7%
3,526
-85.3%
1.04%
-70.7%
DPLO NewDIPLOMAT PHARMACY INC COMstock$800,000,000200,000
+100.0%
0.98%
CTMX BuyCYTOMX THERAPEUTICS INC COMstock$730,250,000
+83.0%
87,876
+62.5%
0.90%
+193.1%
QURE NewUNIQURE NV SHSstock$716,600,00010,000
+100.0%
0.88%
ALC SellALCON INC ORD SHSstock$442,245,000
-97.8%
7,799
-97.7%
0.54%
-96.4%
CISN NewCISION LTD SHSstock$281,124,00028,197
+100.0%
0.34%
BMYRT NewBRISTOL MYERS SQUIBB CO RIGHT 99/99/9999 ADDEDstock$137,858,00045,800
+100.0%
0.17%
CBLK ExitCARBON BLACK INC COMstock$0-1,100
-100.0%
-0.02%
GOLD ExitBARRICK GOLD CORPORATION COMstock$0-7,026
-100.0%
-0.09%
FCAU ExitFIAT CHRYSLER AUTOMOBILES N SHSstock$0-10,879
-100.0%
-0.11%
RACE ExitFERRARI N V COMstock$0-1,261
-100.0%
-0.15%
ONCE ExitSPARK THERAPEUTICS INC COMstock$0-2,253
-100.0%
-0.17%
FTI ExitTECHNIPFMC PLC COMstock$0-15,691
-100.0%
-0.29%
TSU ExitTIM PARTICIPACOES S A SPONSORED ADRstock$0-65,902
-100.0%
-0.73%
GHDX ExitGENOMIC HEALTH INC COMstock$0-30,000
-100.0%
-1.56%
MLNX ExitMELLANOX TECHNOLOGIES LTD SHSstock$0-19,348
-100.0%
-1.63%
CBM ExitCAMBREX CORP COMstock$0-65,127
-100.0%
-2.97%
VSM ExitVERSUM MATLS INC COMstock$0-124,902
-100.0%
-5.07%
DD ExitDUPONT DE NEMOURS INC COMstock$0-125,045
-100.0%
-6.84%
QGEN ExitQIAGEN NV SHS NEWstock$0-282,203
-100.0%
-7.10%
MDSO ExitMEDIDATA SOLUTIONS INC COMstock$0-102,140
-100.0%
-7.17%
CELG ExitCELGENE CORP COMstock$0-95,800
-100.0%
-7.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2020-02-18
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UBS GROUP AG SHS25Q1 202331.8%
T-MOBILE US INC COM25Q3 202323.9%
GOLDMAN SACHS GROUP INC COM16Q3 202314.3%
BRISTOL-MYERS SQUIBB CO COM15Q1 20209.9%
CITIGROUP INC COM NEW15Q4 202218.8%
GILEAD SCIENCES INC COM15Q2 20198.9%
DBV TECHNOLOGIES S A SPONSORED ADR13Q2 20191.7%
CYTOMX THERAPEUTICS INC COM13Q4 20201.3%
MICROSOFT CORP COM12Q4 202219.4%
TIM PARTICIPACOES S A SPONSORED ADR12Q3 201912.2%

View Exane Asset Management's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-23
13F-HR2024-01-24
13F-HR2023-10-20
13F-HR2023-07-17
13F-HR/A2023-05-11
13F-HR2023-04-25
13F-HR2023-01-17
13F-HR2022-10-24
13F-HR2022-07-15
13F-HR2022-04-21

View Exane Asset Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Exane Asset Management's holdings